High Vista Strategies LLC Igm Biosciences, Inc. Transaction History

High Vista Strategies LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$27.59 - $66.39 $426,155 - $1.03 Million	-15,446 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$65.76 - $90.65 $326,498 - $450,077	4,965 Added 47.37%	15,446 $1.02 Million
Q2 2021 Aug 16, 2021	BUY	$57.98 - $96.6 $90,448 - $150,696	1,560 Added 17.49%	10,481 $872,000
Q1 2021 May 17, 2021	SELL	$71.56 - $121.23 $217,041 - $367,690	-3,033 Reduced 25.37%	8,921 $684,000
Q4 2020 Feb 16, 2021	BUY	$47.41 - $115.03 $120,279 - $291,831	2,537 Added 26.94%	11,954 $1.06 Million
Q3 2020 Nov 16, 2020	BUY	$43.0 - $84.01 $140,653 - $274,796	3,271 Added 53.22%	9,417 $695,000
Q2 2020 Aug 14, 2020	BUY	$51.3 - $75.21 $315,289 - $462,240	6,146 New	6,146 $449,000

20.7M

68K

52.2K

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $217M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.